Article: National Sleep Foundation Corrects Statement on Cataplexy Drug

WASHINGTON, July 5 /U.S. Newswire/ -- In a news release issued Tuesday afternoon, July 3 ("National Sleep Foundation Hails FDA Approval of New Drug to Treat Cataplexy"), the National Sleep Foundation (NSF) misinterpreted a ruling by the Food and Drug Administration regarding Xyrem(r), a new drug for treating a symptom of narcolepsy.

...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!